Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Updated the page from Revision v3.0.1 to v3.0.2; removed the 'Back to Top' element.
    Difference
    0.1%
    Check dated 2025-09-15T19:28:47.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-08T15:08:14.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous specific locations across various countries and the introduction of new medical terminology related to medullary thyroid gland carcinoma. Additionally, a key reference to a Phase 3 trial of selpercatinib has been included.
    Difference
    17%
    Check dated 2025-09-01T09:43:05.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-18T02:12:59.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-08-11T00:14:23.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.6%
    Check dated 2025-08-03T17:59:14.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.